Thesis

Street consensus, scenarios, merits, risks, and invalidation triggers

AI-assisted
Thesis Summary

Choice Hotels International (CHH) operates a highly resilient, asset-light hotel franchising model that generates predictable free cash flow. However, near-term headwinds warrant a cautious stance. The company's Q1 2026 results highlighted a significant earnings miss (Adjusted EPS of $1.07 vs. $1.32 consensus) driven by inflationary cost pressures, elevated SG&A, and weaker-than-expected domestic RevPAR. While global net rooms growth of 1.7% and a 72% increase in global franchise agreements awarded signal strong underlying development momentum, domestic market share concerns and flat RevPAR guidance relative to peers who are raising outlooks suggest that the stock is fairly valued at current levels.

Sign in / Sign up to read more
This section is the 12-month view: analyst targets and the probability-weighted scenarios built from them. The intrinsic value at the top of this page answers a different question: what the business is worth today.
Street view · analyst 12-month targets15 analysts · as of 18 Aug 2026
Low · most bearish analyst$86.00
Mean target$114.93
High · most bullish analyst$131.00
Our research · scenarios, merits, risks, and invalidation triggersResearch as of 18 Sep 2026
Scenarios · 12-month scenario targetsAnchored at research date
Bear CaseDownside scenario

Persistent inflationary pressures and elevated labor costs continue to weigh on franchisee profitability, leading to higher-than-expected unit exits and slowing royalty fee growth. Choice continues to lose domestic market share to peers like Wyndham and Marriott, forcing downward revisions to full-year 2026 guidance. A broader slowdown in leisure and business travel demand compresses valuation multiples.

Base CaseCentral scenario

The company successfully executes its transition to a highly capital-efficient model, reducing net capital outlays for hotel development from $103.4 million in 2025 to the guided $20 million to $45 million range in 2026. U.S. net rooms growth continues to inflect positively, supported by conversion-led pipelines. Adjusted EBITDA lands within the guided range of $632 million to $647 million, and Adjusted Diluted EPS meets the full-year target of $6.92 to $7.14. Valuation multiples remain stable as steady international expansion offsets soft domestic RevPAR growth.

Scenarios are anchored to street consensus at the research date, with our probabilities and rationale.

Key Investment Merits
  • Asset-light, fee-based franchising model that generates predictable, high-margin cash flows throughout economic cycles.
  • Strong development pipeline exceeding 77,700 rooms globally, with 97% concentrated in higher-revenue extended-stay, midscale, and upscale segments.
  • Proven capital allocation strategy with active share repurchases and consistent dividend payments, supported by declining capital intensity.
Sign in / Sign up to read more
Key Investment Risks
  • Underperformance in domestic RevPAR and potential market share loss to key competitors in the economy and midscale segments.
  • Franchisee margin compression from elevated labor, supply, and financing costs, which could slow unit development and increase exits.
  • Execution risks associated with international expansion and the scaling of newer brands like Everhome Suites.
Sign in / Sign up to read more
Thesis Invalidation Triggers
  1. A downward revision of the full-year 2026 Adjusted EBITDA guidance below the current $632 million floor.
  2. U.S. net rooms growth reverting to negative territory or failing to sustain sequential improvement.
  3. A sharp decline in the global franchise agreements awarded, indicating a breakdown in the conversion-led development model.
Sign in / Sign up to read more

All scenarios are estimates and subject to change. Past performance is not indicative of future results.

Quality Pillars Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Explore this dossier

AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.